Ecovyst (ECVT) Conference presentation summary
Event summary combining transcript, slides, and related documents.
Conference presentation summary
25 Aug, 2026Business profile and value proposition
Leading provider of regenerated and virgin sulfuric acid, sulfur dioxide, and derivatives essential for customer operations and processes.
Holds #1 or #2 supply share for products generating over 95% of 2025 sales.
Secured long-term customer contracts with cost pass-through and minimum volume protection for over 90% of 2025 sales.
Proprietary production technology and strategically located facilities ensure operational excellence.
Strong balance sheet with net debt leverage ratio of 2.0x as of June 30, 2026.
Product and service portfolio
Offers regenerated and virgin sulfuric acid, sulfur dioxide, sodium bisulfite, sodium thiosulfate, sodium metabisulfite, and catalyst activation services.
Supports key industries: mining, water treatment, energy, food, and pharmaceuticals.
Leading North American provider for both regenerated and virgin sulfuric acid.
Ex-situ catalyst activation for refining, petrochemical, and renewable fuel production.
Strategic acquisitions and supply infrastructure
Acquired Calabrian, the sole on-purpose SO2 producer in North America, with >50% supply share.
Calabrian brings proprietary SO2Clean® technology and a blue-chip customer base.
Production sites in Texas and Canada, with strategic proximity to key customers.
End-to-end supply chain management and production redundancy in key refining locations.
Latest events from Ecovyst
- Q2 2026 sales up 42%, net income doubled, and guidance raised after Calabrian acquisition.ECVT
Q2 2026 - Q1 2025 sales reached $162 million with strong catalyst growth and stable leverage.ECVT
BMO Chemicals 2025 Conference presentation - Q1 2024 delivered higher margins, strong cash flow, and growth in sustainable catalyst markets.ECVT
2024 Wells Fargo Industrials Conference presentation - Q2 2025 sales rose, margins faced pressure, and strategic focus remains on sustainable growth.ECVT
Jefferies 2025 Industrials Conference presentation - Q3 2025 delivered robust sales and EBITDA, with post-divestiture leverage expected below 1.5x.ECVT
Citi 2025 Basic Materials Conference presentation - Q1 2026 saw robust sales and margin growth, supported by strategic expansion and strong cash flow.ECVT
BMO Chemicals 2026 Conference presentation - Q1 2025 sales stable, margins pressured, Zeolyst JV drives catalyst segment growth.ECVT
DB 15th Annual Global Industrials, Materials & Building Products Conference presentation - Q1 2026 delivered strong sales and EBITDA growth, driven by expanded sulfur solutions and robust demand.ECVT
Wells Fargo Industrials Conference presentation - Robust sales, cash flow, and margins with stable leverage and a focus on sustainability.ECVT
Bank of America Securities 2024 Leveraged Finance Conference